Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L12 pseudogene 42 (RPL12P42)
- Target
- RPL12P42
- Molecular classification
- Other (Pseudogene; not a protein, not a functional ribosomal subunit)
01
Overview
Ribosomal protein L12 pseudogene 42 (RPL12P42) is a processed pseudogene in the human genome. It is a non-functional genomic sequence related by homology to the ribosomal protein L12 gene (RPL12), which encodes a component of the 60S ribosomal subunit involved in protein synthesis. Pseudogenes like RPL12P42 do not produce functional proteins and are generally regarded as "genomic fossils" without current biological or therapeutic relevance. They are present as a result of gene duplication or retrotransposition events and are dispersed throughout the genome.
- Other names
- RPL12_15_1630
02
Mechanism of action
None (pseudogenes do not serve as targets for drug action)
03
Biological functions
None (no known functional role; pseudogenes typically do not have biological activity)
04
Disease associations
None (no evidence supports a role in disease for this pseudogene)
05
Safety considerations
None (not a therapeutic target, thus not associated with therapeutic risk)
06
Interacting drugs
None (no known drugs interact with pseudogenes)
07
Biomarkers
None (not used as a biomarker for patient selection or monitoring)
Beyond the preview
Go deeper on Ribosomal protein L12 pseudogene 42 (RPL12P42).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L12 pseudogene 42 (RPL12P42).